{"id":59981,"date":"2026-06-04T22:54:39","date_gmt":"2026-06-04T13:54:39","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4596\/"},"modified":"2026-08-23T13:45:24","modified_gmt":"2026-08-23T04:45:24","slug":"company-4596","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4596\/","title":{"rendered":"KUBOTA PHARMACEUTICAL HLDGS CO"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4596","DATE":"2026-01-09","longName":"Kubota Pharmaceutical Holdings Co., Ltd.","company_name_ja":"","fullTimeEmployees":8,"address":"","phone":"","website":"https:\/\/www.kubotaholdings.co.jp","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":45,"financialCurrency":"","marketCap":5193,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":-10.59,"epsForward":0,"bookValue":0,"totalRevenue":21335000,"OperatingIncome":-894855000,"operatingMargins":-4194.3100000000004,"NetIncome":-676253000,"profitMargins":-3169.6900000000001,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-37.280000000000001,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T03:52:24.457881\", \"ticker\": \"4596\", \"ticker_full\": \"4596.T\", \"company_name\": \"KUBOTA PHARMACEUTICAL HLDGS CO \", \"analyst_recommendations\": {\"has_data\": true, \"recommendation_key\": \"none\", \"recommendation_mean\": null, \"total_analysts\": null, \"strong_buy\": null, \"buy\": null, \"hold\": null, \"sell\": null, \"strong_sell\": null}, \"target_prices\": {\"has_data\": true, \"current\": 59.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 37.37, \"institution_pct\": 5.8, \"major_holders\": [{\"label\": \"\", \"value\": 37.37}, {\"label\": \"\", \"value\": 5.8}, {\"label\": \"\", \"value\": 9.26}, {\"label\": \"\", \"value\": 5.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials. The company was founded in 2002 and is headquartered in Minato, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T01:57:52.441930\", \"ticker\": \"4596\", \"ticker_full\": \"4596.T\", \"company_name\": \"KUBOTA PHARMACEUTICAL HLDGS CO \", \"company_info\": {\"name_en\": \"KUBOTA PHARMACEUTICAL HLDGS CO \", \"long_name\": \"Kubota Pharmaceutical Holdings Co., Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.kubotaholdings.co.jp\", \"employees\": 8, \"country\": \"Japan\", \"city\": \"Minato\", \"address\": \"1-15-37 Minami-Aoyama\", \"description\": \"Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials. The company was founded in 2002 and is headquartered in Minato, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 68.0, \"deviation\": 0.0, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 63.92, \"deviation\": 6.38, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 65.21, \"deviation\": 4.27, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 82.09, \"deviation\": -17.16, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 21335000.0, \"revenue_fmt\": \"\u00a521.3M\", \"gross_profit\": -4799000.0, \"gross_profit_fmt\": \"-\u00a54.8M\", \"operating_income\": -894855000.0, \"operating_income_fmt\": \"-\u00a59\u5104\", \"ebit\": -675381000.0, \"ebit_fmt\": \"-\u00a57\u5104\", \"net_income\": -676253000.0, \"net_income_fmt\": \"-\u00a57\u5104\", \"eps\": -10.59, \"operating_margin\": -4194.31, \"total_assets\": 1979457000.0, \"total_assets_fmt\": \"\u00a520\u5104\", \"total_equity\": 1813832000.0, \"total_equity_fmt\": \"\u00a518\u5104\", \"total_debt\": 127872000.0, \"total_debt_fmt\": \"\u00a51\u5104\", \"total_cash\": 1918615000.0, \"total_cash_fmt\": \"\u00a519\u5104\", \"equity_ratio\": 91.63, \"de_ratio\": 0.07, \"current_ratio\": 12.51, \"operating_cf\": -583000000.0, \"operating_cf_fmt\": \"-\u00a56\u5104\", \"investing_cf\": -3652000.0, \"investing_cf_fmt\": \"-\u00a53.7M\", \"financing_cf\": 1065666000.0, \"financing_cf_fmt\": \"\u00a511\u5104\", \"free_cf\": -593631000.0, \"free_cf_fmt\": \"-\u00a56\u5104\", \"net_margin\": -3169.69, \"roe\": -37.28, \"roa\": -34.16}, {\"year\": 2024, \"revenue\": 27189000.0, \"revenue_fmt\": \"\u00a527.2M\", \"gross_profit\": 22032000.0, \"gross_profit_fmt\": \"\u00a522.0M\", \"operating_income\": -1345491000.0, \"operating_income_fmt\": \"-\u00a513\u5104\", \"ebit\": -1325450000.0, \"ebit_fmt\": \"-\u00a513\u5104\", \"net_income\": -1332852000.0, \"net_income_fmt\": \"-\u00a513\u5104\", \"eps\": -23.65, \"operating_margin\": -4948.66, \"total_assets\": 1541907000.0, \"total_assets_fmt\": \"\u00a515\u5104\", \"total_equity\": 1389755000.0, \"total_equity_fmt\": \"\u00a514\u5104\", \"total_debt\": 63327000.0, \"total_debt_fmt\": \"\u00a563.3M\", \"total_cash\": 1454908000.0, \"total_cash_fmt\": \"\u00a515\u5104\", \"equity_ratio\": 90.13, \"de_ratio\": 0.05, \"current_ratio\": 10.12, \"operating_cf\": -1195075000.0, \"operating_cf_fmt\": \"-\u00a512\u5104\", \"investing_cf\": -43057000.0, \"investing_cf_fmt\": \"-\u00a543.1M\", \"financing_cf\": -88273000.0, \"financing_cf_fmt\": \"-\u00a588.3M\", \"free_cf\": -1244810000.0, \"free_cf_fmt\": \"-\u00a512\u5104\", \"net_margin\": -4902.17, \"roe\": -95.91, \"roa\": -86.44}, {\"year\": 2023, \"revenue\": 39887000.0, \"revenue_fmt\": \"\u00a539.9M\", \"gross_profit\": 28114000.0, \"gross_profit_fmt\": \"\u00a528.1M\", \"operating_income\": -1504006000.0, \"operating_income_fmt\": \"-\u00a515\u5104\", \"ebit\": -1480228000.0, \"ebit_fmt\": \"-\u00a515\u5104\", \"net_income\": -1489602000.0, \"net_income_fmt\": \"-\u00a515\u5104\", \"eps\": -26.79, \"operating_margin\": -3770.67, \"total_assets\": 3016840000.0, \"total_assets_fmt\": \"\u00a530\u5104\", \"total_equity\": 2646732000.0, \"total_equity_fmt\": \"\u00a526\u5104\", \"total_debt\": 252938000.0, \"total_debt_fmt\": \"\u00a53\u5104\", \"total_cash\": 2767639000.0, \"total_cash_fmt\": \"\u00a528\u5104\", \"equity_ratio\": 87.73, \"de_ratio\": 0.1, \"current_ratio\": 10.14, \"operating_cf\": -1335939000.0, \"operating_cf_fmt\": \"-\u00a513\u5104\", \"investing_cf\": -45033000.0, \"investing_cf_fmt\": \"-\u00a545.0M\", \"financing_cf\": 96581000.0, \"financing_cf_fmt\": \"\u00a596.6M\", \"free_cf\": -1402226000.0, \"free_cf_fmt\": \"-\u00a514\u5104\", \"net_margin\": -3734.56, \"roe\": -56.28, \"roa\": -49.38}, {\"year\": 2022, \"revenue\": 8254000.0, \"revenue_fmt\": \"\u00a58.3M\", \"gross_profit\": 2433000.0, \"gross_profit_fmt\": \"\u00a52.4M\", \"operating_income\": -2038020000.0, \"operating_income_fmt\": \"-\u00a520\u5104\", \"ebit\": -2004343000.0, \"ebit_fmt\": \"-\u00a520\u5104\", \"net_income\": -2015906000.0, \"net_income_fmt\": \"-\u00a520\u5104\", \"eps\": -40.92, \"operating_margin\": -24691.3, \"total_assets\": 4419755000.0, \"total_assets_fmt\": \"\u00a544\u5104\", \"total_equity\": 3949535000.0, \"total_equity_fmt\": \"\u00a539\u5104\", \"total_debt\": 343015000.0, \"total_debt_fmt\": \"\u00a53\u5104\", \"total_cash\": 4048969000.0, \"total_cash_fmt\": \"\u00a540\u5104\", \"equity_ratio\": 89.36, \"de_ratio\": 0.09, \"current_ratio\": 11.59, \"operating_cf\": -2086695000.0, \"operating_cf_fmt\": \"-\u00a521\u5104\", \"investing_cf\": 505159000.0, \"investing_cf_fmt\": \"\u00a55\u5104\", \"financing_cf\": 1446787000.0, \"financing_cf_fmt\": \"\u00a514\u5104\", \"free_cf\": -2144671000.0, \"free_cf_fmt\": \"-\u00a521\u5104\", \"net_margin\": -24423.38, \"roe\": -51.04, \"roa\": -45.61}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-59981","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>KUBOTA PHARMACEUTICAL HLDGS CO - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4596\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4596\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4596\/\",\"name\":\"KUBOTA PHARMACEUTICAL HLDGS CO - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T13:54:39+00:00\",\"dateModified\":\"2026-08-23T04:45:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4596\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4596\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4596\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KUBOTA PHARMACEUTICAL HLDGS CO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KUBOTA PHARMACEUTICAL HLDGS CO - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4596\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4596\/","url":"https:\/\/japanir.jp\/en\/company\/company-4596\/","name":"KUBOTA PHARMACEUTICAL HLDGS CO - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T13:54:39+00:00","dateModified":"2026-08-23T04:45:24+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4596\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4596\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4596\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"KUBOTA PHARMACEUTICAL HLDGS CO"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/59981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=59981"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=59981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}